Urine test could reduce invasive cancer biopsies
Researchers from the University of East Anglia have developed a new urine test for prostate cancer which also shows how aggressive the disease is. A...
Tag: prostate cancer
Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth
Prostate cancer: µ-crystallin CRYM protein inhibits tumour growth: Prostate cancer is one of the most commonly diagnosed forms of cancer in men and affects around...
Prostate cancer: immunotherapy offers hope
An antibody for treating advanced prostate cancer improves progression-free survival in patients with metastasised, castration-resistant prostate cancer. This is the finding of the long-term analyses...
Prostate cancer treatment abiraterone not available
Men in England & Wales miss out on abiraterone as first-line treatment for advanced prostate cancer: The Institute of Cancer Research, London, has expressed disappointment...
Test improves detection of Prostate Cancer
New screening test improves detection of Prostate Cancer using circulating tumor cells and prostate-specific markers. Melbourne-based National Institute of Medicine is the first to pioneer...
Feasibility of genetic screening for prostate cancer
Feasibility of genetic screening for prostate cancer Genetic ‘barcoding’ in GP surgeries picks out men at increased risk for follow-up checks Pilot study...
The Continued Evolution of Prostate Cancer Screening
New data will offer a unique insight into whether prostate MRI could be the test that we are looking for to preferentially detect those cancers...
Olaparib Outperforms Targeted Hormone Therapy in Men with Advanced Prostate Cancer
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with...
HIFU is effective against prostate cancer with fewer side effects
Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with fewer side effects. A new study,...
Stephen Fry returns to work after prostate cancer surgery
Just days after revealing he underwent surgery for prostate cancer, 60-year-old actor and TV presenter Stephen Fry has returned to work. Fry announced that he...
